查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1607204

醣質學/糖生物學市場：按產品、應用和最終用戶分類 - 全球預測 2025-2030

Glycomics/Glycobiology Market by Product (Carbohydrates, Enzymes, Instruments), Application (Cell Biology, Disease Diagnostics, Drug Discovery & Development), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年醣質學/糖生物學市場價值為34.9億美元，預計2024年將達到39億美元，複合年成長率為11.87%，到2030年將達到76.7億美元。

醣質學是對生物系統中聚醣的綜合研究，其子集糖生物學正成為重要的研究領域，其市場適用性不斷擴大。由於聚醣在細胞過程和疾病病理學中的重要作用，對醣質學和Glico的需求在於其有可能徹底改變疾病診斷、治療和個人化醫療。應用範圍涵蓋製藥、生物技術和學術研究，在生物標記發現、疫苗開發和了解宿主-病原體相互作用方面的效用不斷增加。最終用途範圍廣泛，涵蓋醫療保健、研究機構以及由聚醣分析技術和生物資訊學創新驅動的快速成長的生物技術領域。

主要市場統計
基準年[2023] 34.9億美元
預計年份 [2024] 39億美元
預測年份 [2030] 76.7億美元
複合年成長率（%） 11.87%

關鍵的成長要素包括質譜和高效液相層析等先進技術，可增強聚醣結構分析。此外，增加對生物技術研發的投資以及對尖端醫療保健解決方案的日益關注正在推動市場擴張。該領域提供了開發基於聚醣的創新療法和診斷的機會，特別是由於癌症和神經退化性疾病等複雜疾病帶來的持續挑戰。為了利用這些機會，相關人員可以專注於生技公司和學術機構之間的策略聯盟，以培養強大的研發開發平臺並投資擴大高通量分析技術。

影響市場成長的挑戰包括聚醣結構的複雜性，這需要先進的分析工具和專業知識，這可能會限制早期實驗室的採用。此外，與這些技術相關的高成本和缺乏訓練有素的專業人員也可能是一個障礙。為了解決這些限制，公司可以透過開發經濟高效、易於使用的分析平台並投資培訓計劃來培養熟練人才來推動創新。總體而言，醣質學和糖生物學市場表現出巨大的成長潛力，特別是透過協同合作和技術進步，從而為生命科學領域的持續業務成長提供利潤豐厚的途徑。

市場動態：快速發展的醣質學/糖生物學市場的關鍵市場洞察

供需的動態交互作用正在改變醣質學/糖生物學市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 增加蛋白質體學和醣質學研究的研發支出和資金
    • 蛋白質體學市場快速成長
    • 個人化醫療需求不斷成長
  • 市場限制因素
    • 嚴格的政府政策和法規
  • 市場機會
    • 醣質學裝置的技術進步
    • 新興市場的生物標記識別
    • 學術研究機構的藥物發現研究活動增加
  • 市場挑戰
    • 對工具高成本的擔憂

波特的五力：駕馭醣質學/糖生物學市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解醣質學/糖生物學市場的外部影響

外部宏觀環境因素在塑造醣質學/糖生物學市場的動態表現方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解醣質學/糖生物學市場的競爭格局

醣質學/糖生物學市場的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位醣質學/糖生物學市場供應商的績效評估

FPNV定位矩陣是評估醣質學/糖生物學市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製醣質學/糖生物學市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對醣質學/糖生物學市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加蛋白質體學和醣質學研究的研發支出和資金
      • 蛋白質體學市場快速成長
      • 個人化醫療需求不斷成長
    • 抑制因素
      • 嚴格的政府政策和法規
    • 機會
      • 醣質學設備的技術進步
      • 新興市場的生物標記識別
      • 學術研究機構的藥物發現研究活動增加
    • 任務
      • 對工具高成本的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第 6 章醣質學/糖生物學市場：依產品

  • 碳水化合物
    • 醣蛋白、醣脂、醣肽
    • 單醣
    • 寡糖
  • 酵素
    • 碳水化合物磺基轉移酶
    • 糖苷酶和神經醯胺酶
    • 糖基轉移酶和唾液酸轉移酶
    • 蛋白質磺基轉移酶和硫酸鹽分解酶
  • 裝置
    • 大批
    • 層析法設備
    • 電泳裝置
    • 高效液相管柱
    • 質譜儀
    • 核磁共振設備
  • 套件
    • 聚醣檢測試劑套件
    • 聚醣富集試劑套件
    • 聚醣標記試劑套件
    • 聚醣精製套件
    • 聚醣釋放套件
    • 聚醣樣品製備試劑套件
  • 試劑/化學品

第 7 章醣質學/糖生物學市場：依應用分類

  • 細胞生物學
  • 疾病診斷
  • 藥物發現與開發
  • 微生物學
  • 病毒學

第 8 章醣質學/糖生物學市場：按最終用戶

  • 學術研究所
  • 臨床實驗室
  • 製藥和生物技術公司

第9章北美和南美的醣質學/糖生物學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太醣質學/糖生物學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的醣質學/糖生物學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Asparia Glycomics
  • Chemily Glycoscience
  • Dextra Laboratories Ltd.
  • Glycomix Ltd.
  • Glyxera GmBH
  • Ludger Ltd.
  • Merck KGaA
  • New England Biolabs, Inc.
  • RayBiotech Life, Inc.
  • Shimadzu Corporation
  • Sumitomo Bakelite Co. Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • Z Biotech, LLC
Product Code: MRR-3D2FD205BD43

The Glycomics/Glycobiology Market was valued at USD 3.49 billion in 2023, expected to reach USD 3.90 billion in 2024, and is projected to grow at a CAGR of 11.87%, to USD 7.67 billion by 2030.

Glycomics, the comprehensive study of glycans in biological systems, and its subset glycobiology, have emerged as crucial areas of research with expanding market applicability. The necessity of glycomics and glycobiology lies in their potential to revolutionize disease diagnostics, therapeutics, and personalized medicine due to glycans' indispensable roles in cellular processes and disease pathology. Applications span across pharmaceuticals, biotechnology, and academic research, with increasing utility in biomarker discovery, vaccine development, and understanding host-pathogen interactions. The end-use scope is extensive, covering healthcare, research institutions, and the burgeoning biotechnology sector, driven by innovations in glycan analysis technologies and bioinformatics.

KEY MARKET STATISTICS
Base Year [2023] USD 3.49 billion
Estimated Year [2024] USD 3.90 billion
Forecast Year [2030] USD 7.67 billion
CAGR (%) 11.87%

Key growth factors include advancing technologies such as mass spectrometry and high-performance liquid chromatography, which enhance glycan structural analyses. Moreover, increasing investment in biotechnology research and development, coupled with a growing focus on cutting-edge healthcare solutions, are driving market expansion. The field presents opportunities in developing innovative glycan-based therapeutics and diagnostics, particularly due to the continued challenges posed by complex diseases like cancer and neurodegenerative disorders. To capitalize on these opportunities, stakeholders may focus on strategic alliances between biotech firms and academic institutions to foster robust research and development pipelines and invest in scaling high-throughput analysis technologies.

Challenges affecting market growth include the intricate nature of glycan structures, which necessitates sophisticated analytical tools and expertise, potentially limiting adoption in early-stage research labs. Additionally, the high costs associated with these technologies and a scarcity of trained specialists may pose barriers. Addressing these limitations, businesses could drive innovation by developing cost-effective, user-friendly analytical platforms and investing in training programs to cultivate a skilled workforce. Overall, the glycomics and glycobiology market presents significant growth potential, particularly through synergistic collaborations and technological advancements, thereby offering lucrative avenues for sustained business growth in the life sciences sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glycomics/Glycobiology Market

The Glycomics/Glycobiology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing R&D expenditure and funding for proteomics and glycomics research
    • Rapid growth of the proteomics market
    • Rising demand for personalized medicine
  • Market Restraints
    • Stringent government policies and regulations
  • Market Opportunities
    • Technological advancements in glycomics instrumentation
    • Biomarker identification in the emerging markets
    • Growing number of drug discovery research activities in academic research institutes
  • Market Challenges
    • Concerns regarding high cost of tools

Porter's Five Forces: A Strategic Tool for Navigating the Glycomics/Glycobiology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glycomics/Glycobiology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glycomics/Glycobiology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glycomics/Glycobiology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glycomics/Glycobiology Market

A detailed market share analysis in the Glycomics/Glycobiology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glycomics/Glycobiology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glycomics/Glycobiology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glycomics/Glycobiology Market

A strategic analysis of the Glycomics/Glycobiology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glycomics/Glycobiology Market, highlighting leading vendors and their innovative profiles. These include Asparia Glycomics, Chemily Glycoscience, Dextra Laboratories Ltd., Glycomix Ltd., Glyxera GmBH, Ludger Ltd., Merck KGaA, New England Biolabs, Inc., RayBiotech Life, Inc., Shimadzu Corporation, Sumitomo Bakelite Co. Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., Waters Corporation, and Z Biotech, LLC.

Market Segmentation & Coverage

This research report categorizes the Glycomics/Glycobiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Carbohydrates, Enzymes, Instruments, Kits, and Reagents & Chemicals. The Carbohydrates is further studied across Glycoproteins, Glycolipids, & Glycol Peptides, Monosaccharides, and Oligosaccharides. The Enzymes is further studied across Carbohydrate Sulfotransferases, Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, and Protein Sulfotransferases & Sulfatases. The Instruments is further studied across Arrays, Chromatography Instruments, Electrophoresis Instruments, HPLC Columns, Mass Spectrometry Instruments, and NMR Instruments. The Kits is further studied across Glycan Detection Kits, Glycan Enrichment Kits, Glycan Labeling Kits, Glycan Purification Kits, Glycan Releasing Kits, and Glycan Sample Preparation Kits.
  • Based on Application, market is studied across Cell Biology, Disease Diagnostics, Drug Discovery & Development, Microbiology, and Virology.
  • Based on End-User, market is studied across Academic Research Institutes, Clinical Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing R&D expenditure and funding for proteomics and glycomics research
      • 5.1.1.2. Rapid growth of the proteomics market
      • 5.1.1.3. Rising demand for personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent government policies and regulations
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in glycomics instrumentation
      • 5.1.3.2. Biomarker identification in the emerging markets
      • 5.1.3.3. Growing number of drug discovery research activities in academic research institutes
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding high cost of tools
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Glycomics/Glycobiology Market, by Product

  • 6.1. Introduction
  • 6.2. Carbohydrates
    • 6.2.1. Glycoproteins, Glycolipids, & Glycol Peptides
    • 6.2.2. Monosaccharides
    • 6.2.3. Oligosaccharides
  • 6.3. Enzymes
    • 6.3.1. Carbohydrate Sulfotransferases
    • 6.3.2. Glycosidases & Neuramidases
    • 6.3.3. Glycosyltransferases & Sialytransferases
    • 6.3.4. Protein Sulfotransferases & Sulfatases
  • 6.4. Instruments
    • 6.4.1. Arrays
    • 6.4.2. Chromatography Instruments
    • 6.4.3. Electrophoresis Instruments
    • 6.4.4. HPLC Columns
    • 6.4.5. Mass Spectrometry Instruments
    • 6.4.6. NMR Instruments
  • 6.5. Kits
    • 6.5.1. Glycan Detection Kits
    • 6.5.2. Glycan Enrichment Kits
    • 6.5.3. Glycan Labeling Kits
    • 6.5.4. Glycan Purification Kits
    • 6.5.5. Glycan Releasing Kits
    • 6.5.6. Glycan Sample Preparation Kits
  • 6.6. Reagents & Chemicals

7. Glycomics/Glycobiology Market, by Application

  • 7.1. Introduction
  • 7.2. Cell Biology
  • 7.3. Disease Diagnostics
  • 7.4. Drug Discovery & Development
  • 7.5. Microbiology
  • 7.6. Virology

8. Glycomics/Glycobiology Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic Research Institutes
  • 8.3. Clinical Laboratories
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Glycomics/Glycobiology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Glycomics/Glycobiology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Glycomics/Glycobiology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Asparia Glycomics
  • 2. Chemily Glycoscience
  • 3. Dextra Laboratories Ltd.
  • 4. Glycomix Ltd.
  • 5. Glyxera GmBH
  • 6. Ludger Ltd.
  • 7. Merck KGaA
  • 8. New England Biolabs, Inc.
  • 9. RayBiotech Life, Inc.
  • 10. Shimadzu Corporation
  • 11. Sumitomo Bakelite Co. Ltd.
  • 12. Takara Bio Inc.
  • 13. Thermo Fisher Scientific Inc.
  • 14. Waters Corporation
  • 15. Z Biotech, LLC

LIST OF FIGURES

  • FIGURE 1. GLYCOMICS/GLYCOBIOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GLYCOMICS/GLYCOBIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GLYCOMICS/GLYCOBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GLYCOMICS/GLYCOBIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLYCOMICS/GLYCOBIOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOPROTEINS, GLYCOLIPIDS, & GLYCOL PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY MONOSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY OLIGOSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATE SULFOTRANSFERASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOSIDASES & NEURAMIDASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOSYLTRANSFERASES & SIALYTRANSFERASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PROTEIN SULFOTRANSFERASES & SULFATASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ELECTROPHORESIS INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY HPLC COLUMNS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY NMR INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN DETECTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN ENRICHMENT KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN LABELING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN PURIFICATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN RELEASING KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN SAMPLE PREPARATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REAGENTS & CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CELL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY VIROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 144. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 151. SINGAPORE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 152. SINGAPORE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. SINGAPORE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH KOREA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 163. TAIWAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 164. TAIWAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 165. TAIWAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 166. TAIWAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. TAIWAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 170. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 171. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 172. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 173. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. THAILAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 177. VIETNAM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 178. VIETNAM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 179. VIETNAM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 180. VIETNAM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. VIETNAM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 192. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 193. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 194. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 195. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. DENMARK GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 199. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 200. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 201. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 202. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. EGYPT GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 206. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 207. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 208. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 209. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. FINLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 213. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 214. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 215. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 216. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 220. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 221. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 222. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 223. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 227. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 228. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 229. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 230. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. ISRAEL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 234. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 235. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 236. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 237. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 242. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 243. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 244. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. NETHERLANDS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 248. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 249. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 250. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 251. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. NIGERIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 255. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 256. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 257. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 258. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. NORWAY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 262. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 263. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 264. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 265. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. POLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 269. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 270. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 271. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 272. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. QATAR GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 276. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 277. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 278. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 279. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 284. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 285. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 286. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 292. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 293. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 297. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 298. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 299. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 300. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 304. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 305. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 306. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 307. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. SWEDEN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 311. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 312. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 313. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 314. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. SWITZERLAND GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 318. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 319. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 320. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 321. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. TURKEY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 332. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 333. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 334. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 335. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 336. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 337. GLYCOMICS/GLYCOBIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 338. GLYCOMICS/GLYCOBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023